Advancements in the Treatment of Glioblastoma: "More Drug is Not Always Better"
Sep 30, 2021 ·
49m 57s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Nader Sanai, MD. Dr. Sanai is the director of the Ivy Brain Tumor Center and the director of...
show more
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Nader Sanai, MD.
Dr. Sanai is the director of the Ivy Brain Tumor Center and the director of neurosurgical oncology at the Barrow Neurological Institute in Phoenix, Arizona. In this episode of the program Hofland asked Sanai about Phase 0 studies – also known as micro-dosing studies – and why they are so important in the development of promising new drugs. They also talk about a potential, non-invasive treatment option for glioblastoma as well as and data Dr. Sanai presented during the annual meeting of the European Society for Medical Oncology the meeting of the European Association for Neuro-Oncology.
About The Onco'Zine Brief
The Onco'Zine Brief is distributed in the United States via PRX (Public Radio Exchange). In the United Kingdom and Europe, the program is distributed via UK Health Radio (UKHR). And the program can be downloaded via most podcasts and streaming media services, including iTunes, Spotify, TuneIn, and iHeart Radio.
For more information about The Onco'Zine Brief or how to sponsor or support this public radio broadcast and podcast, visit: https://www.patreon.com/theoncozinebrief
For more information about cancer and cancer treatments, visit our online journal Onco'Zine at www.oncozine.com
To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.
show less
Dr. Sanai is the director of the Ivy Brain Tumor Center and the director of neurosurgical oncology at the Barrow Neurological Institute in Phoenix, Arizona. In this episode of the program Hofland asked Sanai about Phase 0 studies – also known as micro-dosing studies – and why they are so important in the development of promising new drugs. They also talk about a potential, non-invasive treatment option for glioblastoma as well as and data Dr. Sanai presented during the annual meeting of the European Society for Medical Oncology the meeting of the European Association for Neuro-Oncology.
About The Onco'Zine Brief
The Onco'Zine Brief is distributed in the United States via PRX (Public Radio Exchange). In the United Kingdom and Europe, the program is distributed via UK Health Radio (UKHR). And the program can be downloaded via most podcasts and streaming media services, including iTunes, Spotify, TuneIn, and iHeart Radio.
For more information about The Onco'Zine Brief or how to sponsor or support this public radio broadcast and podcast, visit: https://www.patreon.com/theoncozinebrief
For more information about cancer and cancer treatments, visit our online journal Onco'Zine at www.oncozine.com
To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.
Information
| Author | Peter Hofland |
| Organization | Peter Hofland |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments